Meet the Mentors in Cancer Prevention and Control
The mentors in the Interdisciplinary Cancer Prevention and Control training program are award-winning scientists with expertise in nearly every field of research.
The mentors in the Interdisciplinary Cancer Prevention and Control training program are award-winning scientists with expertise in nearly every field of research.
Program Director
Victoria L. Champion, PhD, RN, FAAN
Research areas: oncology care; early detection; symptom intervention; quality of life |
Co-Leader
Catherine Mosher, PhD
Research areas:(1) developing, evaluating, and disseminating psychosocial interventions for cancer patients and their family caregivers; and (2) identifying demographic, medical, and social predictors of physical and psychological health outcomes in cancer patients and their family caregivers. |
Interdisciplinary Mentors
Matthew C. Aalsma, PhD
Research areas: Pediatrics, addiction, mental health and physical health care for children and adolescents, juvenile justice systems, implementation science |
Janet Carpenter, PhD, RN, FAAN
Research areas: Menopause, hot flashes, women's health, nonhormonal management of hot flashes. |
Teresa Damush, PhD, MA, BA
Research areas: Patient self-management, health psychology, implementation science |
Brian Dixon, PhD, MPA FACMI, FHIMSS
Research areas: Informatics methods; public health; population health |
David Haggstrom, MD, MAS
Research areas: Cancer health services research; cancer care coordination; medical informatics; health information exchange & data analytics |
Jiali Han, PhD
Research areas: Epidemiology studies of cancer etiology, prevention, outcome and global health. |
Susan Hickman, PhD
Research areas: advance care planning; end-of-life decision-making; goals of care; geriatrics; ethics. |
Adam T. Hirsh, PhD
Research areas: Clinical psychology; biopsychosocial aspects of pain and functioning in humans; racial disparities in pain management. |
Kun Huang, PhD
Research areas: Translational bioinformatics and integrative genomics tools for cancer precision medicine. |
Karen Hudmon, DrPH
Research areas: Screening and surveillance of colorectal neoplasia. Tailoring of colorectal cancer screening and surveillance based on individual patient risk. Understanding test characteristics of non-invasive colorectal cancer screening tests. Technology assessment for digestive diseases |
Thomas Imperiale, MD
Research areas: Screening and surveillance of colorectal neoplasia. Tailoring of colorectal cancer screening and surveillance based on individual patient risk. Understanding test characteristics of non-invasive colorectal cancer screening tests. Technology assessment for digestive diseases |
Shelley Johns, PsyD, HSPP, ABPP
Research areas: symptom management in post-treatment cancer survivors |
Research areas: human papillomavirus (HPV); cancer |
Mark Kelley, PhD
Research areas: Translational research in DNA damage and repair, specifically, to determine how those activities can be exploited therapeutically to treat cancers and protect normal cells from oxidative and DNA base damage. |
Kurt Kroenke, MD
Research areas: chronic pain; patient-reported outcome measures; symptom evaluation/management; mental health in primary care |
Brenna McDonald, PsyD
Research areas: To improve understanding of the brain basis for cognitive symptoms experienced by cancer patients, and to develop treatments that help improve symptoms, daily functioning, and quality of life. |
Nir Menachemi, PhD, MPH
Research areas: How organizational strategies (e.g., health information technology adoption) impact critical performance measures, including quality outcomes and financial performance; health policy. |
Patrick Monahan, PhD
Research areas: Differential item functioning and development and validation of scales; statistical research in the areas of psychometrics and measurement. |
Research areas: Mechanisms of anti-estrogen resistance, cancer stem cells and metastasis in breast cancer. |
Sheri Robb, PhD, MT-BC
Research areas: Music-based interventions to manage distress and improve positive health outcomes in children/adolescents with cancer and their caregivers. |
Andrew Saykin, PsyD
Research areas: Neural Mechanisms of Chemotherapy-Induced Cognitive Disorder |
Todd Skaar, PhD
Research areas: Pharmacogenetics; breast cancer; discovery and implementation of genomic predictors of drug response. |
Lois Travis, MD, ScD
Research areas: Long-term physiologic and psychosocial effects of cancer and its treatment, with a goal of providing a foundation for risk-adapted evidence-based follow-up. |
To learn more about the Cancer Prevention and Control program, please send an email, along with your CV, to Nikki Benbow at nholdcro@iu.edu.